Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd C Metzger

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
The Journal of Clinical Investigation|March 26, 2011
Myocarditis: a defect in central immune tolerance?Todd C Metzger, Mark S Anderson
Immunological Reviews|April 15, 2011
Control of central and peripheral tolerance by AireTodd C Metzger, Mark S Anderson
Journal of Immunology (Baltimore, Md. : 1950)|April 10, 2020
GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-AntigenMatthew P Rausch, Lydia R Meador, Todd C Metzger, et al.
Cell Stem Cell|May 21, 2013
Generation of functional thymic epithelium from human embryonic stem cells that supports host T cell developmentAudrey V Parent, Holger A Russ, Imran S Khan, et al.
Cell Reports|October 8, 2013
Lineage tracing and cell ablation identify a post-Aire-expressing thymic epithelial cell populationTodd C Metzger, Imran S Khan, James M Gardner, et al.
Cancer Research|May 20, 2016
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor RejectionTodd C Metzger, Hua Long, Shobha Potluri, et al.
Immunity|September 3, 2013
Extrathymic Aire-expressing cells are a distinct bone marrow-derived population that induce functional inactivation of CD4⁺ T cellsJames M Gardner, Todd C Metzger, Eileen J McMahon, et al.
Science Translational Medicine|October 11, 2013
BPIFB1 is a lung-specific autoantigen associated with interstitial lung diseaseAnthony K Shum, Mohammad Alimohammadi, Catherine L Tan, et al.
Nature|July 20, 2018
Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte developmentCorey N Miller, Irina Proekt, Jakob von Moltke, et al.
Journal of Medicinal Chemistry|October 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor ImmunosuppressionJared T Moore, Hiroyuki Kawai, Brian R Blank, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
The Journal of Clinical Investigation|March 26, 2011
Myocarditis: a defect in central immune tolerance?Todd C Metzger, Mark S Anderson
Immunological Reviews|April 15, 2011
Control of central and peripheral tolerance by AireTodd C Metzger, Mark S Anderson
Journal of Immunology (Baltimore, Md. : 1950)|April 10, 2020
GILT in Thymic Epithelial Cells Facilitates Central CD4 T Cell Tolerance to a Tissue-Restricted, Melanoma-Associated Self-AntigenMatthew P Rausch, Lydia R Meador, Todd C Metzger, et al.
Cell Stem Cell|May 21, 2013
Generation of functional thymic epithelium from human embryonic stem cells that supports host T cell developmentAudrey V Parent, Holger A Russ, Imran S Khan, et al.
Cell Reports|October 8, 2013
Lineage tracing and cell ablation identify a post-Aire-expressing thymic epithelial cell populationTodd C Metzger, Imran S Khan, James M Gardner, et al.
Cancer Research|May 20, 2016
ICOS Promotes the Function of CD4+ Effector T Cells during Anti-OX40-Mediated Tumor RejectionTodd C Metzger, Hua Long, Shobha Potluri, et al.
Immunity|September 3, 2013
Extrathymic Aire-expressing cells are a distinct bone marrow-derived population that induce functional inactivation of CD4⁺ T cellsJames M Gardner, Todd C Metzger, Eileen J McMahon, et al.
Science Translational Medicine|October 11, 2013
BPIFB1 is a lung-specific autoantigen associated with interstitial lung diseaseAnthony K Shum, Mohammad Alimohammadi, Catherine L Tan, et al.
Nature|July 20, 2018
Thymic tuft cells promote an IL-4-enriched medulla and shape thymocyte developmentCorey N Miller, Irina Proekt, Jakob von Moltke, et al.
Journal of Medicinal Chemistry|October 26, 2025
Discovery of ORIC-533, an Orally Bioavailable CD73 Inhibitor That Maintains Activity in High AMP Environments to Reverse Tumor ImmunosuppressionJared T Moore, Hiroyuki Kawai, Brian R Blank, et al.
Pageof 1